United States-based Abbott (NYSE: ABT) announced on Friday its quarterly common dividend.
The company has declared a dividend of USD0.51 per share.
The dividend will be paid to shareholders of record as at 14 July 2023, on 15 August 2023.
Abbott is a global healthcare with a portfolio of life-changing technologies which spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US
Aurisco announces Yangzhou, China manufacturing site's successful FDA inspection
Teva Pharmaceuticals and Alvotech expand biosimilars partnership in the US
Sandoz to invest USD90m in Biosimilar Technical Development Center in Slovenia
Brenzavvy Now Available for the Treatment of Adults with Type 2 Diabetes
Dr. Reddy's Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
Dr. Reddy's rituximab biosimilar candidate undergoes regulatory review in the US, EU and UK
Grossman Named President and Chief Medical Officer at Coya Therapeutics
Endo International launches first generic version of Merck's Noxafil